Table 2.
Incremental dose administered per route/regimen for the first 18 subjects as a sentinel group for safety monitoring (IM=intramuscular; IN=intranasal; S=subject)
| 1st Dose | Low Dose (LD) (107.0 EID50%/dose) |
Medium Dose (MD) (107.5 EID 50%/dose) |
High Dose (HD) (108.0 EID 50%/dose) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Day1 | Day 2 | Day3 | Day 4 | Day 5 | Day 6 | Day 7 | Day 8 | Day 9 | |
| IM | S1 | S3 | S5 | S7 | S9 | S11 | S13 | S15 | S17 |
| IN | S2 | S4 | S6 | S8 | S10 | S12 | S14 | S16 | S18 |
| Evaluation by an Independent Safety Committee 7 days after last High Titer vaccination | |||||||||